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Introduction
Cell cycle progression after DNA damage is rapidly halted by 
checkpoint controls, which are relaxed after the damage has 
been assessed and processed. Cells with misrepaired or unre-
paired DNA lesions are eliminated by different cell death mech-
anisms (Zhou and Elledge, 2000; Roninson et al., 2001; Bree 
et al., 2004). One such mechanism is mitotic cell death (MCD), 
which is also known as “mitotic catastrophe,” a prominent but 
poorly defi  ned form of cell death that is described mainly in 
morphological terms. MCD is an outcome of aberrant mitosis 
that results in the formation of giant multimicronucleated cells 
(Erenpreisa and Cragg, 2001; Roninson et al., 2001). It is a 
  major form of tumor cell death after treatments with ionizing 
radiation (IR) or certain chemotherapeutic agents (Torres and 
Horwitz, 1998; Roninson et al., 2001; Blank et al., 2003).
MCD has been shown to prevail in cells with impaired 
G1, G2, prophase, and mitotic spindle checkpoint functions 
(Chan et al., 2000; Roninson et al., 2001; Nitta et al., 2004). 
A prominent cell cycle checkpoint is activated by DNA double-
strand breaks (DSBs) at the G2/M boundary. Activation of this 
checkpoint is driven by the nuclear protein kinase ataxia telangi-
ectasia mutated (ATM), its downstream substrates p53 and 
the Chk1 and Chk2 kinases, Polo-like kinase 1 (Plk-1), and the 
p53-inducible proteins p21
waf1 and 14-3-3-σ. The p53-mediated 
arm of the G2/M checkpoint was shown to be pivotal in preventing 
MCD in DNA-damaged cells (Chan et al., 2000; Fei and 
El-Deiry, 2003), although some studies challenge this observation 
(Andreassen et al., 2001; Castedo et al., 2004).
MCD has been assumed to result from the entry into mi-
tosis of cells with unrepaired DNA damage, although a mecha-
nism linking DNA lesions with mitotic abnormalities has yet to 
be uncovered. One of the early steps in the chain of events that 
culminates in MCD is cell entry into premature mitosis (Chan 
et al., 2000; Roninson et al., 2001; Nitta et al., 2004). To date, 
evidence of premature mitosis in damaged cells relies primarily 
on the appearance of uneven chromatin condensation (UCC), 
which is the formation of hypercondensed chromatin aggre-
gates at nucleolar sites (Swanson et al., 1995; Ianzini and 
Mackey, 1997; Roninson et al., 2001). The mechanisms under-
lying this phenomenon are unknown.
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During normal progression through mitosis, the structural 
reorganization of chromatin into condensed chromosomes en-
tails the multiprotein complexes condensin I and II (Schmiesing 
et al., 1998; Swedlow and Hirano, 2003; Ono et al., 2004). 
In vitro studies showed that condensin I possesses a DNA-
  stimulated ATPase activity and is capable of introducing con-
strained, positive supercoils into DNA (Hirano, 2002). This 
activity is believed to be essential for initiating the assembly of 
mitotic chromosomes and for proper assembly and orientation 
of centromeres (Hagstrom et al., 2002; Ono et al., 2004). The 
two condensin complexes are each composed of fi  ve  sub-
units conserved from yeast to mammals (Hirano et al., 1997; 
Schmiesing et al., 2000; Kimura et al., 2001). The core complex 
common to both condensins consists of the structural mainte-
nance of chromosomes (SMC) proteins CAP-E/SMC2 and 
CAP-C/SMC4. Two other members of this family, SMC1 
and SMC3, form the core of the cohesin complex that plays 
a central role in sister chromatid cohesion (Hirano, 2002). Each 
condensin complex then contains a regulatory subcomplex 
  consisting of three non-SMC proteins. In condensin I, these are 
CAP-D2, -G, and -H. CAP-D2 and -G possess a highly degen-
erate repeating motif known as the HEAT repeat (Neuwald 
and Hirano, 2000), whereas CAP-H belongs to a recently identi-
fi  ed superfamily of proteins termed kleisins (Schleiffer et al., 
2003). In condensin II, the regulatory subcomplex contains the 
proteins CAP-D3, -G2, and -H2 (Fig. 1 A; Ono et al., 2003; 
Yeong et al., 2003). 
During interphase, both types of condensins appear to be 
localized in the cytosol and the nucleus (Cabello et al., 2001; 
Watrin and Legagneux, 2005), with condensin I being predo-
minantly cytosolic and condensin II being primarily nuclear 
(Ono et al., 2003; Hirota et al., 2004). The two condensin com-
plexes localize in different places along mitotic chromosomes 
assembled in vitro and in vivo, suggesting distinct functions in 
chromosome architecture (Hirota et al., 2004; Ono et al., 2003, 
2004). Importantly, in vitro studies indicated that cyclin-dependent 
  kinase 1 (Cdk1)–mediated phosphorylation of the non-SMC sub-
unit set is required for chromosomal localization of condensin I 
and stimulation of its supercoiling activity (Kimura et al., 
1998, 2001).
Another prominent type of chromatin condensation noted 
in mammalian cells is apoptosis-related condensation. It is be-
lieved to be mediated primarily by the nuclear protein acinus 
(apoptotic chromatin condensation inducer in the nucleus) after 
its cleavage by activated caspase 3 (Sahara et al., 1999). Acinus 
lacks the DNase activities exhibited by other cellular factors 
that can induce apoptotic chromatin condensation via DNA 
fragmentation. Therefore, acinus functions as a “pure” regulator 
of apoptosis-related chromatin condensation (Zamzami and 
Kroemer, 1999).
Figure 1.  DNA damage triggers the recruitment of condensin core subunits to damaged chromatin and the formation of UCC bodies. (A) Schematic of the 
condensin I and II complexes. H, G, and D2 denote condensin I non-SMC subunits hCAP-H, hCAP-G, and hCAP-D2, respectively. H2, G2, and D3 denote 
condensin II non-SMC subunits hCAP-H2, hCAP-G2, and hCAP-D3, respectively. (B) Recruitment of condensin proteins and UCC in HeLa cells after treat-
ments with NCS. The cells were treated with 200 ng/ml NCS and immunostained 24 h later with anti-SMC2 antibody (red). DNA was counterstained with 
Yo-Pro-1 (green) or DAPI (blue). Bars, 8 μm. (C) Western blotting analysis of chromatin fractions obtained from untreated HeLa cells and 24 h after treatment 
with 200 ng/ml NCS, demonstrating recruitment of SMC2 and SMC4 to chromatin in response to the treatment. (D) Treatment of DNA-damaged cells with 
DNase-I leads to the dissociation of condensin proteins from DNA. Arrows indicate the nucleolar sites where UCC is formed. Arrows with asterisks in 
  DNase-I–treated cells indicate nucleolar locations. Note the disappearance of condensin recruitment after DNase-I treatment. Bars, 20 μm.MITOTIC CELL DEATH AND DNA DAMAGE • BLANK ET AL. 197
In this study, we show that induction of the highly cyto-
toxic DSBs in DNA of cells with compromised p53-mediated 
G2/M checkpoint functions triggers UCC and premature 
  mitosis. We demonstrate that the unscheduled activation of Cdk1 
and the recruitment of activated condensin I to damaged chro-
matin are specifi  cally involved in UCC formation. Condensin II 
and cohesin proteins are not involved in this process. Impor-
tantly, the acinus-mediated pathway, which is responsible for 
apoptotic chromatin condensation, was also not found to oper-
ate in UCC. Using a panel of tumor cell lines, we show that the 
defective damage-induced, p53-mediated G2/M checkpoint is 
an important but not a sole requirement for the activation of 
this pathway.
Results
Condensin but not cohesin is recruited 
to chromatin during UCC induced by DSBs
DNA damage–induced MCD, with UCC as an early step, has 
been shown to occur at high rates in tumor cells in which cell 
cycle checkpoint functions are impaired (Roninson et al., 2001). 
We studied this phenomenon in human cervix carcinoma HeLa 
cells in which the G1 and G2 DNA damage checkpoint func-
tions are compromised as a result of p53 inactivation by human 
papilloma virus E6 (Scheffner et al., 1990). UCC was induced 
in exponentially growing HeLa cells by treatment with 10 Gy IR 
or 200 ng/ml neocarzinostatin (NCS), a radiomimetic agent that 
intercalates into cellular DNA and induces DSBs (Goldberg, 
1987). 24 h later, confocal microscopy revealed that cellular 
DNA was condensed into globular clumped structures typical of 
UCC (Fig. 1 B and Fig. S1 A, available at http://www.jcb.org/
cgi/content/full/jcb.200604022/DC1). This phenomenon was 
observed with two different DNA dyes: DAPI and Yo-Pro-1, 
a monomeric green fl  uorescent cyanine with a high affi  nity for 
double-stranded DNA (Suzuki et al., 1997). Importantly, these 
globular structures contained the condensin core subunits SMC2 
(Fig. 1 B) and SMC4 (Fig. S2), whose nuclear localization 
changed after treatment from a diffuse, pannuclear pattern to 
a compact one that overlapped the UCC bodies. Western blot-
ting analysis of chromatin fractions confi  rmed the recruit-
ment of SMC2 and SMC4 to chromatin in response to DNA 
damage (Fig. 1 C). Accordingly, DNase-I treatment in situ led 
to   dissociation of the UCC bodies and release of the associated 
SMC2 (Fig. 1 D).
DSB-induced UCC was dose dependent and maximized 
at 24 h after treatment (Fig. S2). The percentage of cells exhibi-
ting UCC increased from 5 ± 2% in untreated cells to 65.8 ± 
25.1% 24 h after 200 ng/ml NCS (P < 0.01; n = 6). Importantly, 
the spatial distribution of the cohesin subunit SMC1 was not 
altered (unpublished data), suggesting that the cohesin   complex 
was not involved in this phenomenon. UV irradiation did not 
induce this process (Fig. S1 B), suggesting that it was asso-
ciated specifi   cally with DSBs. Importantly, a similar rate 
of UCC induction was observed in both ATM-profi  cient and 
Figure 2.  Colocalization of UCC and coalesced nucleoli. (A) Simultaneous detection of the NCS-triggered recruitment of SMC2 (green) to UCC bodies and 
their colocalization with nucleoli marked by nucleostemin (NS) staining (red). DNA (DAPI) appears in blue. Note the nucleolar disruption after UV treatment 
versus nucleolar coalescence and colocalization of the resultant large nucleolar bodies with UCC bodies after NCS treatment. Bars, 20 μm. (B)   Visualization 
of NCS-triggered UCC colocalized with coalesced nucleoli using immunostaining with an antinucleolin antibody. Nucleolin, green; SMC2, red; DNA 
(DAPI), blue. Bars, 8 μm.JCB • VOLUME 174 • NUMBER 2 • 2006  198
ATM-defi  cient HeLa cells in which ATM had been knocked 
down using stable expression of the appropriate short hairpin 
RNA (shRNA; Fig. S3, available at http://www.jcb.org/cgi/
content/full/jcb.200604022/DC1).
Collectively, the results suggest that UCC is a delayed cel-
lular response to DSBs that involves condensin but not cohesin 
complexes and apparently does not rely on the presence of ATM 
protein in the cells. It is noteworthy that UCC induction and 
  recruitment of condensin proteins to chromatin after DNA dam-
age were not strictly confi  ned to HeLa but were also observed in 
other cell lines in which cell cycle checkpoints had been com-
promised, although at signifi  cantly lower rates compared with 
HeLa cells (see the last paragraph in Results).
Colocalization of UCC bodies 
with coalescent nucleoli
According to our Nomarski images (Fig. 1, B and D), UCC struc-
tures colocalized with nucleoli, a phenomenon that has been pre-
viously reported (Swanson et al., 1995; Ianzini and Mackey, 1997; 
Roninson et al., 2001). However, although the mean number of 
nucleoli in untreated cells was about three per nucleus, most of 
the nuclei with damage-induced UCC contained a single nucleolar 
body (Fig. 1, B and D). These nucleolar bodies were signifi  cantly 
larger than normal nucleoli: their major axis was measured 
as 5.82 ± 0.93 μm in damaged cells versus 3.06 ± 1.35 μm in 
untreated cells (P < 0.001). To examine this phenomenon further, 
nucleoli were visualized by immunostaining with antibodies 
  ag  ainst the nucleolar proteins GNL3 (guanine nucleotide-binding 
proteinlike 3; nucleostemin; Tsai and McKay, 2002; Tsai and 
McKay, 2005) and nucleolin (Tuteja and Tuteja, 1998). Although 
UV irradiation led to nucleolar disruption and release of nu-
cleolar proteins into the nucleoplasm as previously described 
(Al-Baker et al., 2004; Tsai and McKay, 2005), in NCS-treated 
cells, the nucleolar proteins remained within a single nucleolar 
body that colocalized with the UCC bodies (Fig. 2). 
Condensin proteins are not involved 
in apoptotic chromatin condensation
HeLa cells are capable of activating the apoptotic cell death 
  pathway (Byun et al., 2001), making them suitable for determining
Figure 3.  Condensin proteins participate in mitotic 
chromatin condensation and in UCC but not in apop-
totic chromatin condensation. (A) Induction of apopto-
sis in HeLa cells by staurosporine treatment. PARP-1 
cleavage is detected in staurosporine-treated cells 
(1 μM for 3.5 h). Note the absence of this response in 
NCS-treated cells (200 ng/ml). U, untreated; St, stauro-
sporine treated. (B) Western blotting analysis of 
  chromatin fractions from NCS- and staurosporine-
treated HeLa cells demonstrates condensin recruitment 
to chromatin in damage-induced UCC but not in apop-
totic chromatin condensation. (C) Three types of chro-
matin condensation in HeLa cells: mitotic, apoptotic, 
and damage-induced UCC. Immunoﬂ  uorescence  im-
ages taken from logarithmically growing HeLa cells 
treated with 1 μM staurosporine (for 3.5 h) or 
200 ng/ml NCS (for 24 h). SMC2, red; DNA (Yo-Pro-1), 
green. Bars, 20 μm. (D) Visualization of three types 
of chromatin condensation in HeLa cells stained with 
both anti-SMC2 (red) and anti–HP-1α (green) anti-
bodies. DNA (DAPI), blue. Bars, 8 μm.MITOTIC CELL DEATH AND DNA DAMAGE • BLANK ET AL. 199
whether the recruitment of condensin to chromatin is specifi  c 
to UCC or also accompanies apoptotic chromatin   condensation. 
HeLa cells were treated with NCS or staurosporine, a docu-
mented apoptosis inducer (Couldwell et al., 1994), and the 
induction of apoptosis was monitored by following poly
(ADP-ribose)polymerase-1 (PARP-1) cleavage (Fig. 3 A; Soldani 
and Scovassi, 2002). The apoptotic chromatin condensa-
tion was morphologically distinct from damage-induced UCC 
and, unlike UCC and mitotic chromatin condensation, did not 
involve condensin recruitment (Fig. 3 C). In fact, in apoptotic 
cells, the chromatin-bound SMC2 fraction was reduced com-
pared with untreated cells (Fig. 3 B), conceivably because of 
apoptosis-associated DNA fragmentation, which subsequently 
released SMC2 from chromatin.
To further demonstrate the differential recruitment of 
SMC2 to chromatin upon different types of chromatin conden-
sation, we compared its distribution with that of HP-1α (hetero-
chromatin protein 1α). HP-1α is known to constitutively 
associate with condensed chromatin in interphase and mitotic 
cells (Minc et al., 1999). We found that HP-1α was associated 
with condensed DNA in all three types of chromatin condensa-
tion that we studied (mitotic, apoptotic, and UCC), whereas 
SMC2 was loaded onto DNA in mitosis and upon UCC but not 
upon apoptotic chromatin condensation (Fig. 3 D).  Interestingly, 
HP-1α and SMC2 were colocalized in normal mitotic 
  chromosomes and in UCC bodies, but HP-1α was observed 
mainly in subcompartments of these structures, particularly 
in the inner core of the UCC bodies (Fig. S4, available at 
http://www.jcb.org/cgi/content/full/jcb.200604022/DC1).
Condensin I but not condensin II 
is involved in UCC
SMC2 and SMC4 constitute the common cores of the condensin 
I and II complexes (Ono et al., 2003; Yeong et al., 2003). The 
condensin I–related protein hCAP-H (human chromatin-
  associated protein H; kleisin-γ) and the condensin II–related 
protein hCAP-H2 (kleisin-β) are thought to be the fi  rst of the 
non-SMC subcomplex proteins to bind to SMC2/SMC4 hetero-
dimers, subsequently recruiting other non-SMC subunits to 
form the complete type I or II condensin complexes, respec-
tively (Nasmyth and Haering, 2005). We found that the conden-
sin I–associated protein hCAP-H but not condensin II–related 
hCAP-H2 was associated with damage-induced UCC bodies 
(Fig. 4 A). Accordingly, biochemical analysis of cytosolic, 
  nucleoplasmic, and chromatin fractions confi  rmed that hCAP-H, 
similar to condensin core subunits, was recruited to the damaged 
Figure 4.  Condensin I but not condensin II is recruited 
to chromatin after DNA damage. (A) NCS- (200 ng/ml 
for 24 h) and IR (10 Gy for 24 h)-induced DNA 
  damage triggers the recruitment to DNA of condensin I 
subunit hCAP-H but not condensin II subunit hCAP-H2. 
Note that DNA staining (DAPI) reveals the formation 
of UCC bodies in both hCAP-H– and hCAP-H2–stained 
ﬁ  elds. Bars, 20 μm. (B) Western blotting analysis of 
chromatin fractions demonstrates recruitment of hCAP-H 
(condensin I) but not hCAP-H2   (condensin II) to dam-
aged chromatin 24 h after NCS treatment. Protein 
loadings and degree of   fractionations are demonstrated 
by using antibodies against the   cytosolic α-tubulin, 
the nucleoplasmic ATM, and the chromatin compo-
nent histone H2B. (C) λ-phosphatase (λ-PPase) treat-
ment abolishes the shift of chromatin-bound hCAP-H. 
Western blotting analyses performed on chromatin 
fractions obtained from NCS-treated (200 ng/ml 
for 24 h) and untreated cells.JCB • VOLUME 174 • NUMBER 2 • 2006  200
chromatin, but hCAP-H2 was not (Fig. 4 B). These results sug-
gest that of the two condensin complexes, condensin I but not 
condensin II is involved in damage-induced UCC.
In the aforementioned experiments, we noticed slower gel 
migration of chromatin-bound hCAP-H compared with soluble 
hCAP-H (Fig. 4 B), suggesting that chromatin-bound hCAP-H 
underwent posttranslational modifi  cations. During mitotic chro-
matin condensation, the non-SMC subunits of condensin I and 
  presumably condensin II undergo Cdk1/cyclin B–mediated 
phosphorylation, which is required for condensin targeting to 
chromatin and its subsequent functionality (Kimura et al., 1998, 
2001). We asked whether hCAP-H that had been recruited to 
chromatin upon UCC was phosphorylated. We treated the chro-
matin fractions with λ-phosphatase before Western blotting 
analysis and found that this treatment indeed abolished the shift 
in hCAP-H migration (Fig. 4 C). This result suggests that simi-
lar to its recruitment to mitotic chromatin, condensin I is re-
cruited to chromatin during UCC as an activated complex.
Unscheduled Cdk1 activation, recruitment 
of condensin I to chromatin, and UCC 
are hallmarks of premature mitosis
UCC is a morphological hallmark of premature mitosis that is 
typical of cells with a defective G2/M checkpoint (Roninson 
et al., 2001). Our data suggest that recruitment of condensin I 
to chromatin is a biochemical marker of this process. To sub-
stantiate the link between a defective G2/M checkpoint and pre-
mature mitosis, we examined this process in HeLa cells, in which 
the G2/M checkpoint is compromised, and the human osteo-
sarcoma cell line U2OS, in which p53 and the G2/M checkpoint 
are functional. Signifi  cantly, U2OS cells exhibited neither UCC 
nor condensin recruitment to chromatin after the same radiomi-
metic treatment that induced them in HeLa cells (Fig. 5, A and B), 
even after prolonged time periods (up to 48 h) following high 
NCS doses (≥200 ng/ml). 
One of the biochemical markers of the G2→M transition 
is elevated phosphorylation of histone 3 on Ser10, which has 
been associated with the loading of condensins onto chromatin 
and chromatin condensation at the early stages of mitosis (Sauve 
et al., 1999; Schmiesing et al., 2000). We noticed that UCC-
  inducing treatments led to histone 3 hyperphosphorylation 
in HeLa but not in U2OS cells (Fig. 5 B), suggesting that 
DNA damage in HeLa cells indeed leads to premature mitosis. 
To substantiate this conclusion, we used FACS analyses to dem-
onstrate the G2/M and mitotic fractions in both cell types after 
DNA damage. The results (Fig. 5 C) showed that a vast majority 
of the HeLa cells were at G2/M 24 h after the treatment, with 
>70% of the cells being in mitosis. In contrast, the G2/M 
  population in U2OS cells consisted mainly of cells at G2; 
here, the mitotic fraction decreased from 1.3 to 0.4% after NCS 
treatment. Accordingly, the G2/M arrest in U2OS cells was 
  correlated with elevated levels of p53 and p21
waf1 (Fig. 5 D), 
which are both required for sustaining the G2/M checkpoint 
(Bunz et al., 1998).
Because damage-induced premature mitosis in HeLa cells 
was characterized by histone 3 phosphorylation, a hallmark of 
normal mitosis, we examined whether premature mitosis was 
also associated with Cdk1 activation, which is an important 
  requirement for the initiation of normal mitosis (Morgan, 1997). 
The activation status of Cdk1 can be monitored by comparing 
the extent of its phosphorylation on Tyr15 (inhibitory phosphor-
ylation) and Thr161 (activating phosphorylation; Makela et al., 
1994; Fletcher et al., 2002). Therefore, Cdk1 activation was 
compared in HeLa and U2OS cells after DNA damage. We found 
that in U2OS cells 24–48 h after treatment, Cdk1 exhibited the 
expected phosphorylation of Tyr15 that is typical for G2/M-
  arrested cells (Fig. 5 E). The level of cyclin B, Cdk1’s regulatory 
subunit that is highly expressed at G2/M and decreases as the 
cells progress through mitosis, was also markedly elevated 
24–48 h after NCS treatment and began to decrease thereafter 
(Fig. 5 E). These results indicate that the G2/M arrest in DNA-
damaged U2OS cells lasted for at least 48 h after treatment. 
FACS analysis supported these conclusions (unpublished data). 
Interestingly, in HeLa cells, Cdk1 was hyperphosphorylated on 
both Tyr15 (inhibitory phosphorylation) and Thr161 (activating 
phosphorylation; Fig. 5 E). Cyclin B levels were markedly 
  elevated 24 h after NCS treatment but declined signifi  cantly 
thereafter (Fig. 5 E).
We compared this unique Cdk1 phosphorylation pattern 
with Cdk1 phosphorylation in HeLa cells artifi  cially arrested 
in mitosis using colcemid treatment. In metaphase-arrested 
cells, the expected dephosphorylation of Tyr15 occurred con-
comitantly with the hyperphosphorylation of Thr161 (Fig. 5 F). 
This experiment allowed us to demonstrate the sharp difference 
between this pattern of Cdk1 phosphorylation and the one ob-
served in DNA-damaged cells, in which Cdk1 was hyperphos-
phorylated on both Thr161 and Tyr15 (Fig. 5 F).
Cell fractionation further revealed that after NCS treatment, 
cyclin B/pT161-Cdk1 (activated complex) was predominantly 
nuclear, whereas inactivated Cdk1, which was tagged by pTyr15, 
was largely sequestered in the cytosol (Fig. 5 G). These fi  ndings 
indicate that the induction of DSBs leads to unscheduled Cdk1 
activation with the appearance of two Cdk1 pools exhibiting 
  distinct subcellular localizations. Collectively, our data provide 
insights into the mechanism of damage-induced UCC and sug-
gest that the unscheduled activation of Cdk1, recruitment of con-
densin I to chromatin, and UCC together lead to (and represent) 
a hallmark of premature mitosis and could serve as useful mark-
ers for distinguishing premature from regular mitotic events.
Premature mitosis precedes MCD 
rather than apoptosis
We asked whether cells that react to extensive damage with UCC 
and premature mitosis (HeLa) will activate a different death path-
way compared with cells that activate the G2/M checkpoint in the 
face of such damage and do not exhibit premature mitosis (U2OS). 
The results are summarized in Fig. 6. 3 d after damage infl  iction, 
U2OS cells exhibited typical morphological and biochemical fea-
tures of apoptosis: pyknosis with the condensation of chromatin, 
nuclear fragmentation, phosphorylation of Ser46 of p53 (Fridman 
and Lowe, 2003), activation of caspase 3, and subsequent cleav-
age of its downstream substrates such as acinus (a marker of 
apoptosis-related chromatin condensation) and PARP (Fig. 6, 
A and B). On the other hand, the same DNA   damage led in HeLa MITOTIC CELL DEATH AND DNA DAMAGE • BLANK ET AL. 201
Figure 5.  Biochemical analysis of premature mitosis versus G2/M arrest and normal mitotic events. (A) Condensin recruitment and UCC develop in 
DNA-damaged HeLa but not in U2OS cells. Cells were treated with NCS (200 ng/ml for 24 h), immunostained with anti-SMC2 antibody (red), and counter-
stained with DAPI (blue). Bars, 20 μm. (B) Western blotting analyses of chromatin fractions from NCS-treated (200 ng/ml for 24 h) HeLa and U2OS cells. 
Note that in HeLa cells, recruitment of SMC2 to damaged chromatin coincides with the phosphorylation of histone 3 on Ser10 (p-H3). (C)   Biparametric 
FACS analysis demonstrating that DNA damage drives HeLa cells into mitosis and arrests U2OS cells in G2/M. The ﬁ  gure represents one of three inde-
pendent experiments. (D) Levels of expression of p53 and its inducible regulator p21
waf1 in DNA-damaged U2OS cells. U24 and U72 represent two untreated 
controls obtained at 24 and 72 h, respectively. (E) Western blotting analysis of G2→M transition regulators in DNA-damaged cells. Total cell lysates were 
obtained from NCS-treated U2OS and HeLa cells 24–72 h after 200 ng/ml NCS administration. U24 and U72 represent two untreated controls obtained 
at 24 and 72 h, respectively. Hsc70 was used as a loading control. (F) Comparative analysis of Cdk1 phosphorylation pattern in DNA-damaged and 
  mitotic-arrested HeLa cells. Cells were either treated with 200 ng/ml NCS (for 24 h) or arrested in metaphase using colcemid. Total cell lysates were ana-
lyzed by Western blotting. (G) DNA damage leads to the appearance of two Cdk1 pools marked with the activating phosphorylation on Thr161 or the 
  inhibitory phosphorylation on Tyr15, each with a distinct subcellular localization. Cytosolic and nuclear fractions were prepared from untreated and NCS-
treated HeLa cells 24–72 h after the treatment and subjected to Western blotting analysis. The degree of fractionation is demonstrated using antibodies 
against α-tubulin and PARP-1, reﬂ  ecting cytosolic and nuclear protein fractions, respectively. Asterisks in the cytosol fraction of the PARP-1 immunoblot 
  denote the cross-reactive bands. JCB • VOLUME 174 • NUMBER 2 • 2006  202
cells to the appearance of giant multimicronucleated cells, 
which is a hallmark of MCD (Fig. 6, A and C). Caspase 3, acinus, 
and PARP remained intact in these cells (Fig. 6 B). FACS analy-
sis supported the occurrence of apoptosis in U2OS cells, with 
the sub-G1 fraction increasing approximately ninefold, whereas 
the same treatment in HeLa cells resulted in only a 1.7-fold in-
crease in the sub-G1 fraction (unpublished data).
We concluded that the process that begins in HeLa cells 
with UCC and premature mitosis and eventually culminates in 
MCD involves mechanisms distinct from those operative in 
apoptosis, whereas G2/M arrest typical of U2OS cells leads to 
apoptotic cell death.
Defective G2/M checkpoint is important 
but is not the only requirement 
for the UCC–MCD pathway
The role of the p53-mediated G2/M checkpoint in MCD is 
  currently unresolved (Bunz et al., 1998; Chan et al., 1999; 
  Andreassen et al., 2001; Castedo et al., 2004). Data reported 
here imply that a compromised p53-mediated G2/M checkpoint 
might be associated with MCD, but the role of p53 in preventing 
MCD requires further substantiation. We examined MCD in 
a panel of tumor cell lines with different p53 constitutions. 
We also stably knocked down p53 in U2OS cells by expressing 
in them an appropriate shRNA. The p53 status and functionality 
(measured by the ability to induce the gene encoding p21
waf1) 
in these cell lines are demonstrated in Fig. S5 A (available at 
http://www.jcb.org/cgi/content/full/jcb.200604022/DC1). After 
NCS treatment, UCC was observed in three cell lines in which 
p53 was impaired—HeLa, 293T, and HCT166 (p53
−/−) cells—
but not in other p53-compromised cell lines (Table I and Fig. 
S5 B). Neither increasing the NCS dose (≥500 ng/ml) nor pro-
longing cell exposure to this drug (up to 48 h) changed these re-
sults  (unpublished data). Accordingly, 72 h after NCS treatment, 
MCD was observed only in HeLa, 293T, and HCT166 (p53
−/−) 
cells (Table I and Fig. S5 C) but not in the cell lines that did not 
exhibit UCC. Notably, the highest levels of MCD was observed 
in HeLa cells (60–70%), whereas MCD levels in 293T and 
HCT166 (p53
−/−) cells reached only 15–20%. Apoptosis was 
the other prominent type of cell death noted to occur at high 
rates in all of these cell lines (with the exception of HeLa cells) 
after DNA damage (Fig. S5 C).
Discussion
MCD results from aberrant mitosis, which fails to produce proper 
chromosome alignment and subsequent chromosome segrega-
tion, and culminates in the formation of large polynucleated cells 
(Erenpreisa and Cragg, 2001; Roninson et al., 2001). Abnormal 
mitosis in drug-treated or irradiated cells may proceed through 
several different pathways, but the fi  nal step is almost always the 
Figure 6. DNA damage–induced MCD engages 
mechanisms distinct from those operative in apoptosis. 
(A) HeLa and U2OS cells undergoing MCD and apop-
tosis after DNA damage, respectively. The cells were 
treated with 200 ng/ml NCS for 72 h, immunostained 
with SMC2 (red), and counterstained with DAPI. The 
ﬁ  gure represents merged images. Bottom panels show 
the appearance of apoptosis and MCD in NCS-treated 
cells stained with Hemacolor reagents and photo-
graphed under light microscopy. M-labeled arrows in-
dicate MCD, and A-labeled arrows denote apoptotic 
features (pyknosis, apoptotic chromatin condensation, 
and nuclear fragmentation). Bars, 20 μm. (B) DNA-
damaged U2OS but not HeLa cells exhibit biochemi-
cal markers of apoptosis. The cells were treated with 
200 ng/ml NCS for periods ranging from 24 to 72 h. 
Total cell extracts were analyzed by Western blotting. 
U, untreated samples. Hsc70 was used as a loading 
control. (C) MCD develops in DNA-damaged HeLa 
cells (200 ng/ml NCS for 72 h) at high frequency. 
The percentages of mono-, bi-, and polynucleated 
(more than three nuclei) cells were calculated from a 
total of 300 counted cells (n = 4). Each bar represents 
the mean ± SD (error bars). 
Table I. Condensin recruitment and activation of the UCC–MCD 
  pathway in a panel of human cell lines with different p53 constitutions 
treated with NCS
Cell lines p53 status Condensin recruitment 
and UCC
MCD
HeLa Inactivated ++
U2OS
wt Wild type – –
U20S
shLacZ Wild type – –
U20S
shp53 Knocked down – –
293T Inactivated ++
HCT116
wt Wild type – –
HCT116
p53−/− Knocked out ++
MDA-MB-231 Mutated – –
MDA-MB-435 Mutated – –
Cells were treated with ≥200 ng/ml NCS and examined for UCC and MCD at 
24 and 72 h, respectively. In HEK 293T cells (293T), p53 is stabilized and in-
activated by SV40 large T antigen (Ahuja et al., 2005). In HCT116 (p53
−/−) cells, 
the TP53 gene encoding p53 was inactivated using homologous recombination 
(Bunz et al., 1998). In MDA-MB-231 and -435 cells, both TP53 alleles are 
inactivated by mutations (Gartel et al., 2003). In HeLa cells, p53 is inactivated 
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formation of nuclear envelopes around individual clusters of 
missegregated chromosomes (Roninson et al., 2001).
At least two mechanisms have been proposed for MCD. 
The fi  rst one is based on the aberrant duplication of centrosomes 
that leads to multipolar mitosis and subsequent formation of 
  micronuclei (Sato et al., 2000). The second one is based on cell 
entry into premature mitosis, implying that cells proceed into 
mitosis before the completion of S or G2 phase. Such cells can-
not properly compact their chromatin and segregate their chromo-
somes and must be eliminated. This mechanism offers an 
attractive explanation for DNA damage–induced MCD, but the 
evidence for premature mitosis in damaged cells has rested 
  primarily on the morphological observations of UCC, whose 
mechanism is elusive (Roninson et al., 2001). Thus, elucidation 
of the molecular pathways underlying these processes is a pre-
requisite to understanding MCD. In this study, we provide some 
of the missing components of this process.
Although damage-induced UCC appears, at least morpho-
logically, to differ from other types of chromatin condensation 
in eukaryotic cells such as mitotic or apoptotic chromatin con-
densation, the question arises whether the mechanisms involved 
in mitotic or apoptotic chromatin condensations are involved in 
MCD-related UCC. We demonstrated that UCC engages some 
of the proteins involved in mitotic chromatin packaging but not 
the acinus-mediated mechanism that operates in apoptotic chro-
matin condensation. Condensin recruitment was found to be a com-
mon denominator of mitotic chromatin condensation and UCC, 
but UCC involved activated condensin I and not condensin II, 
thereby differing from mitosis, which entails the recruitment of 
both condensins to chromatin (Hagstrom et al., 2002; Ono et al., 
2004). Because condensin recruitment is important for proper 
chromosome alignment and subsequent segregation, the exclu-
sive targeting of condensin I to damaged chromatin might lead 
to the formation of unaligned, hypercondensed chromatin ag-
gregates typical of UCC.
Another difference between cell progression through nor-
mal mitosis and premature mitosis is unscheduled activation of 
Cdk1. In contrast to cells entering mitosis normally, Cdk1 in 
premature mitosis undergoes unscheduled activation, resulting 
in the appearance of two Cdk1 pools with different subcellular 
localizations. We showed that cyclin B/pThr161-activated Cdk1 
is localized predominantly in the nucleus, whereas Cdk1, which 
is inactivated by Tyr15 phosphorylation, is sequestered pri-
marily in the cytosol. This division of Cdk1 into two pools may 
refl  ect two populations of Cdk1 molecules, each characterized 
by different posttranslational modifi  cations and each probably 
  capable of responding to different stimuli or interacting with 
different regulators.
DNA damage–induced UCC was noted previously to 
develop in close proximity to the nucleolar site (Roninson 
et al., 2001). Our fi  ndings, although confi  rming these obser-
vations, also indicate that the number of nucleoli in such cells 
was markedly reduced, mainly to a single enlarged nucleolus. 
We propose that the UCC might entail coalescence of the 
  nucleoli. A similar change in nucleolar morphology resulting 
in a single, enlarged nucleolar body was shown in HeLa cells 
after DNA damage induced by the alkylating agent MNNG 
(Alvarez-Gonzalez et al., 1999), but the underlying mecha-
nisms were unknown. Unscheduled activation of Cdk1 in 
cells with UCC might explain this phenomenon. Because 
Cdk1 was shown to play a role in the maintenance of func-
tional nucleoli and perturbation of its activation was associ-
ated with dramatic changes in nucleolar organization (Sirri 
et al., 2002), it is reasonable to assume that the unscheduled 
activation of Cdk1 could lead to the changes in nucleolar 
morphology. Furthermore, alteration of the nucleolar mor-
phology after DNA damage could result from the marked 
changes in the spatial distribution of condensin. It has been 
recently shown that condensin could take part in nucleolar 
  organization by the arrangement of rDNA gene repeats into 
  heterochromatic-like structures thorough its interactions with 
Sir2p (Machin et al., 2004), a histone deacetylase that deacetyl-
ates histone tails to generate a hypoacetylated histone envi-
ronment characteristic of heterochromatin.
The UCC–MCD pathway was primarily observed in cells 
with compromised p53-mediated G2/M checkpoint functions 
(Chan et al., 2000; Fei and El-Deiry, 2003), although its pivotal role 
in preventing MCD has recently been questioned (Andreassen et al., 
2001; Castedo et al., 2004). In our panel of several human 
cell lines with compromised p53, an impaired p53-  mediated 
G2/M checkpoint was not the sole requirement for   activation 
of the UCC–MCD pathway after extensive DNA damage. 
  Presumably, the combination of compromised p53 and im-
paired function of other mediators of G2/M progression are 
  responsible for this phenomenon. Among the possible candi-
dates for such mediators are Chk1, Plk-1, and the Aurora A 
kinase, which were recently shown to play a key role in the 
  reactivation of Cdk1 and onset of mitosis after DNA damage 
(Krystyniak et al., 2006). In addition, it has recently been shown 
that in cells with compromised p53, p73, another member of 
the p53-like family of proteins, can at least partly substitute for 
p53 in cell cycle regulation (Ozaki and Nakagawara, 2005), 
making p73 still another possible candidate for involvement in 
IR-induced MCD.
It is noteworthy that ATM, the chief regulator of cellular 
responses to DSBs, was uninvolved in this pathway. In the face 
of DSBs, ATM mediates the pathways leading to cellular rescue 
and survival on the one hand and apoptosis on the other (Bree 
et al., 2004; Rashi-Elkeles et al., 2006). The ATM-dependent 
apoptotic response relies on functional p53 (Morgan and  Kastan, 
1997; Fridman and Lowe, 2003). Our fi  ndings suggest that 
the UCC–MCD pathway is turned on in cells that are destined 
to die and cannot activate the ATM–p53-mediated apoptotic 
pathway. This is probably one of the very few DSB-triggered 
pathways that are ATM independent. This observation draws 
a line between DSB-induced processes that are under ATM 
  jurisdiction and those that are not.
In summary, our fi  ndings disclose a cell death pathway 
that is triggered by the extensive induction of DSBs, is ATM 
  independent, and is distinct from the apoptotic pathway. It leads 
to the unscheduled activation of Cdk1 followed by premature 
mitosis characterized by UCC that is associated with recruit-
ment of condensin I to chromatin and ultimately to MCD (Fig. 7). 
Thus, the unscheduled activation of Cdk1 and phosphorylation JCB • VOLUME 174 • NUMBER 2 • 2006  204
of the non-SMC subunits of condensin I could be sequentially 
linked. Considering the importance of this pathway in the re-
sponse of tumor cells to radiotherapy and chemotherapy, further 
elucidation of its molecular steps is crucial for understanding 
the action of anticancer drugs and the rational design of thera-
peutic regimens.
Materials and methods
Antibodies and reagents
The following antibodies were used in this study: α-SMC2 (BL548) and 
α-SMC4 (BL551) were obtained from Bethyl Laboratories, Inc.; anti–hCAP-H 
and hCAP-H2 were provided by J.-M. Peters (Research Institute of Molecular 
Pathology, Vienna, Austria); α-SMC1 was a gift from R. Jessberger (Mount 
Sinai School of Medicine, New York, NY); α-nucleolin (7G2) was a gift 
from Y. Shav-Tal (Bar-Ilan University, Ramat-Gan, Israel); α–HP-1α was 
  purchased from Chemicon; α-nucleostemin was obtained from R&D 
  Systems; α-phospho-Cdk1 (pTyr15), α-phospho-Cdk1 (pThr161), α-phospho-
p53 (Ser46), α-cleaved caspase 3 (5A1), and α–PARP-1 were obtained 
from Cell Signaling Technology, Inc.; anti-H2B, α-p53 (DO-1), α-Hsc70, 
and  α-Cdc2 p34 were obtained from Santa Cruz Biotechnology, Inc.; 
α-p21
waf1 (C19) was obtained from Delta Biolabs; α-acinus (C terminus) 
and α-phospho-histone H3 were purchased from Upstate Biotechnology; 
α-tubulin was obtained from Sigma-Aldrich; and α–cyclin B was obtained 
from BD Transduction Laboratories. Secondary HRP-conjugated as well as 
rhodamine red– and FITC-conjugated antibodies were purchased from 
Jackson ImmunoResearch Laboratories.
DNase-free RNase, DNase-I RNase free, and DAPI were purchased 
from Roche Diagnostics; Yo-Pro-1 was obtained from Invitrogen. Stauro-
sporine was obtained from Cell Signaling Technology, colcemid was pur-
chased from Calbiochem, and NCS was purchased from Kayaka Chemicals.
Cell cultures
HeLa and U2OS cells were obtained from American Type Culture Collec-
tion, MDA-MD-231 and MDA-MB-435 cells were a gift from I. Tsarfaty 
(Tel Aviv University, Tel Aviv, Israel), and HCT116 cells and their p53-null 
variant (HCT116 p53
+/+ and HCT116 p53
−/−, respectively) were gifts 
from B. Vogelstein (Johns Hopkins University, Baltimore, MD). Cells were 
cultured in the recommended growth media under standard conditions.
DNA damage
DNA damage was induced either by adding NCS to the cultures, by X irra-
diation using an irradiator (MGC40; Philips), or by UV-C irradiation using 
an irradiator (FLX-35M; Vilber Lourmat) at dose ranges of 30–50 J/m
2.
Confocal and light microscopy
Cells were ﬁ   xed in methanol-acetone (1:1) at −20°C for 5 min. After 
RNase or DNase-I treatments, the cells were blocked in 3% BSA and 
immuno  stained. DNA was counterstained with 1 μM Yo-Pro-1 or 0.1 μg/ml 
DAPI. The samples were mounted using an aqueous mounting medium 
(Biomeda) and subjected to confocal microscopy using the AOBS system 
(TCS SP2; Leica) with a HCXPLAPOL NA 1.2 objective lens. All confocal 
images were taken with a 63× water correction objective and operated by 
confocal software (LCS Lite, version 2.5 Build 1347; Leica).
Apoptosis and MCD were visualized by light microscopy. The cells 
were ﬁ  xed in methanol, stained with Hemacolor reagents (Merck) as pre-
viously described (Blank et al., 2003), and photographed under a light 
  microscope (Eclipse TE 2000-5; Nikon) with a 20× NA 0.45 plain Fluor 
objective. All comparative images (treated vs. untreated samples) were 
  obtained under identical microscope and camera settings.
DNase treatment
Cells grown on coverslips were treated with DNase-I diluted in Tris-buffered 
saline (25 mM Tris-HCl, pH 7.5) containing 1% BSA and supplemented 
with 5 mM MgSO4 for 1 h at 23°C) as described previously (Barrett et al., 
2001). The cells were either directly processed for immunostaining or were 
processed after extraction of their cleaved DNA (with buffer containing 
20 mM Tris-HCl, pH 7.5, 0.25 M ammonium sulfate, and 0.2 mM MgCl2).
Preparation of protein extracts and immunoblotting
Total cell lysates were prepared using radioimmunoprecipitation buffer 
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% IGEPAL, 0.1% SDS, and 
0.5% sodium deoxycholate) supplemented with a mixture of protease and 
phosphatase inhibitors. Nuclear and cytosolic extracts were obtained as 
previously described (Blank et al., 2003). In brief, cytosolic extracts were 
prepared using buffer A (10 mM Hepes, pH 7.9, 10 mM KCl, 1 mM EDTA, 
1 mM EGTA, and 1 mM DTT supplemented with a mixture of protease and 
phosphatase inhibitors and 0.6% NP-40). Nuclear extracts were prepared 
by the dissolution of nuclei in buffer C (20 mM Hepes, pH 7.9, 400 mM 
KCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and a mixture of protease and 
phosphatase inhibitors) using vortex at 4°C for 45 min. Soluble chromatin 
fractions were subsequently prepared from the previous step by sonication 
(40% amplitude; three pulses at 20 s each on ice) in radioimmunoprecipi-
tation buffer. Protein content was calibrated using the bicinchoninic acid 
protein assay reagent kit (Pierce Chemical Co.). The samples were sub-
jected to standard Western blotting analysis. Immunoblots (polyvinylidene 
diﬂ   uoride) were visualized using enhanced chemiluminescence (Super-
Signal, Pierce Chemical Co.).
Phosphatase treatment
Reactions were performed on solubilized chromatin fractions in 1× PTase 
buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.1 mM EGTA, 2 mM 
DTT, and 0.01% Brij 35) supplemented with MnCl2 using 400 U λ-protein 
phosphatase (λ-PPase; New England Biolabs, Inc.) per 100 μg of extracted 
proteins at 30°C for 1 h and were stopped by supplementation to 50 mM 
EDTA. The extracts were analyzed directly by immunoblotting.
Biparametric ﬂ  ow cytometric analysis
Cells were analyzed by two-dimensional ﬂ  ow cytometry after costaining 
with an antibody against phosphorylated histone 3 (H3-p, a mitotic marker) 
and propidium iodide (PI) for DNA quantitation. In brief, cells were ﬁ  xed, 
permeabilized with 0.25% Triton X-100, incubated with the H3-p antibody, 
labeled with FITC-conjugated anti–rabbit IgG secondary antibody, treated 
with 5 μg/ml DNase-free RNase (37°C for 30 min), and stained with PI. 
Data were collected using FACSort ﬂ  ow cytometry (Becton Dickinson) with 
H3-p in the ﬁ  rst and PI in the second dimension (10,000 events/sample). 
Cell cycle gating and analysis were performed using WinMDI software.
Generation of mitosis-sequestered cells
Logarithmically growing cultures of HeLa cells were mitotically arrested 
by treatment with 0.1 μg/ml colcemid for 17 h as described previously 
(Duesbery et al., 1997), collected by shake-off, and subjected to Western 
blotting analysis. FACS analysis conﬁ  rmed that >90% of colcemid-treated 
cells were in M phase.
RNA interference
p53 was stably knocked down in U20S cells by expressing the appropriate 
shRNA in them using the pRETRO-SUPER retroviral vector (Brummelkamp 
et al., 2002). The sequence 5′-G  A  T  C  C  C  C  G  A  C  T  C  C  A  G  T  G  G  T  A  A  T  C  T  A  C  T  T-
C  A  A  G  A  G  A  G  T  A  G  A  T  T  A  C  C  A  C  T  G   G  A  G  T  C  T  T  T  T  T  G  G  A  A  A  -’3 was cloned in 
the vector using BglII and HindIII restriction sites.
ATM was knocked down in HeLa cells using a combination of two 
different shRNAs: ATM-I (7218), 5′-G  A  T  C  C  C  C  C  T  G  G  T  T  A  G  C  A  G  A  A  A  C  -
G  T  G  C  T  T  C  A  A  G  A  G  A  G  C  A   C  G  T  T  T  C  T  G  C  T  A  A  C  C  A  G  T  T  T  T  T  G  G  A  A  A  -’3; and 
ATM-II (p480), 5′-G  A  T  C  C  C  C  G  A  T  A  C  C  A  G  A  T  C  C  T  T  G  G  A  G  A  T  T  C  A  A  G  A  G   
A  T  C  T  C  C  A  A  G  G  A  T  C  T  G  G  T  A  T  C  T  T  T  T  T  G  G  A  A  A  -3′ (a gift from R. Agami, 
Netherlands Cancer Institute, Amsterdam, Netherlands).
Irrelevant shRNA against the lacZ operon was used as a control. 
Cells were infected with retroviral particles according to standard protocols 
Figure 7.  Proposed mechanisms of premature mitosis and MCD in 
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and subjected to selection with puromycin (for shp53 cells) or a combina-
tion of puromycin and hygromycin (for shATM cells).
Statistics
Data were analyzed using the two-tailed t test. P values of <0.05 were 
considered statistically signiﬁ  cant.
Online supplemental material
Fig. S1 shows that IR and NCS but not UV trigger the recruitment of con-
densin core subunits to damaged chromatin and the formation of UCC 
bodies. Fig. S2 shows that condensin recruitment and UCC develop in 
HeLa cells as a delayed cellular response to severe DNA damage. Fig. S3 
shows that ATM knockdown does not alter the rate of DSB-induced UCC. 
Fig. S4 shows that condensin and HP-1α strictly colocalize in normal mito-
sis but occupy different compartments in UCC bodies associated with 
  premature mitosis. Fig. S5 shows that the defective p53-mediated G2/M 
checkpoint is important for condensin recruitment, UCC, and MCD but is 
not the sole requirement. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200604022/DC1.
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